NCT06278402View on ClinicalTrials.gov

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

January 6, 2024

Study Completion Date

January 16, 2024

Conditions
Alopecia AreataAlopecia TotalisAlopecia Universalis
Interventions
DRUG

Tofacitinib

Oral tofacitinib 5mg twice daily for treatment of alopecia areata, totalis and universalis.

Trial Locations (1)

Unknown

Misbah Zari Qadir, Karachi

All Listed Sponsors
lead

Jinnah Hospital

OTHER